World's Best Scientists 2026 revealed!

Samuel Waxman publications per year

1968: 2 publications 1969: 5 publications 1970: 4 publications 1971: 1 publications 1972: 0 publications 1973: 6 publications 1974: 3 publications 1975: 6 publications 1976: 2 publications 1977: 3 publications 1978: 2 publications 1979: 2 publications 1980: 4 publications 1981: 2 publications 1982: 7 publications 1983: 6 publications 1984: 0 publications 1985: 2 publications 1986: 0 publications 1987: 1 publications 1988: 3 publications 1989: 3 publications 1990: 1 publications 1991: 1 publications 1992: 0 publications 1993: 2 publications 1994: 1 publications 1995: 0 publications 1996: 3 publications 1997: 4 publications 1998: 5 publications 1999: 7 publications 2000: 4 publications 2001: 4 publications 2002: 12 publications 2003: 5 publications 2004: 7 publications 2005: 9 publications 2006: 7 publications 2007: 10 publications 2008: 7 publications 2009: 3 publications 2010: 5 publications 2011: 8 publications 2012: 3 publications 2013: 3 publications 2014: 4 publications 2015: 10 publications 2016: 3 publications 2017: 4 publications 2018: 2 publications 2019: 0 publications 2020: 1 publications 2021: 2 publications 2022: 2 publications 2023: 65 publications 2024: 5 publications 2025: 3 publications
1968 2025

276 publications in total across all disciplines

Samuel Waxman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Samuel Waxman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

The last bar groups every scientist with 1,796 publications or more.

Samuel Waxman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Samuel Waxman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

The last bar groups every scientist with 217 D-Index or more.

Overview

Samuel Waxman is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research activity predominantly spans the fields of Biochemistry, Genetics and Molecular Biology, as well as Medicine. Within these areas, their work is especially concentrated in subfields such as Molecular Biology, Hematology, and Oncology, with additional focus on Cancer Research and Aging.

The scientist's main research topics include cell death mechanisms and regulation, acute myeloid leukemia research, cancer therapeutics and mechanisms, histone deacetylase inhibitors research, and retinoids in leukemia and cellular processes. They have also contributed to studies involving genetics, aging, and longevity in model organisms, along with protein degradation and inhibitors.

Samuel Waxman has published multiple articles in notable scientific venues. Frequent publication outlets include Cancer Research with six papers, Aging and Cancer with two papers, and one paper each in Aging, Translational Oncology, and Cell Death and Disease.

Recent publications cover diverse areas of cancer biology and therapeutics. Examples include:

  • Cancer mortality in the oldest old: a global overview (2020, Aging)
  • Invasive phenotype in triple negative breast cancer is inhibited by blocking SIN3A-PF1 interaction through KLF9 mediated repression of ITGA6 and ITGB1 (2021, Translational Oncology)
  • Artesunate improves venetoclax plus cytarabine AML cell targeting by regulating the Noxa/Bim/Mcl-1/p-Chk1 axis (2022, Cell Death and Disease)
  • The GSK3β/Mcl-1 axis is regulated by both FLT3-ITD and Axl and determines the apoptosis induction abilities of FLT3-ITD inhibitors (2023, Cell Death Discovery)
  • Replacing the tropolonic methoxyl group of colchicine with methylamino increases tubulin binding affinity with improved therapeutic index and overcomes paclitaxel cross-resistance (2023, Drug Resistance Updates)

The scientist has collaborated frequently with several colleagues, including Yongkui Jing (11 publications), Linxiang Zhao (6 publications), Ping Gong (4 publications), Jingyi Zhang (3 publications), and Yuetong Wang (3 publications).

Best Publications

  • Mechanisms of action of arsenic trioxide.

    Wilson H. Miller;Hyman M. Schipper;Janet S. Lee;Jack Singer

  • Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL) : I. As2O3 exerts dose-dependent dual effects on APL cells

    Guo-Qiang Chen;Xue-Geng Shi;Wei Tang;Shu-Min Xiong

  • Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia.

    Zhu Chen;Nigel J. Brand;Alex Chen;Sai Juan Chen

  • Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma

    Augusto Villanueva;Derek Y. Chiang;Pippa Newell;Judit Peix

  • Malignant Cells Can Be Sensitized to Undergo Growth Inhibition and Apoptosis by Arsenic Trioxide Through Modulation of the Glutathione Redox System

    Jie Dai;Rona S. Weinberg;Samuel Waxman;Yongkui Jing

  • Arsenic Trioxide Selectively Induces Acute Promyelocytic Leukemia Cell Apoptosis Via a Hydrogen Peroxide-Dependent Pathway

    Yongkui Jing;Jie Dai;Ruth M.E. Chalmers-Redman;Willam G. Tatton

  • Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features

    Daniela Sia;Yang Jiao;Iris Martinez-Quetglas;Olga Kuchuk;Olga Kuchuk

  • All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia.

    Zhi-Xiang Shen;Zhan-Zhong Shi;Jing Fang;Bai-Wei Gu

  • Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma

    Derek Y. Chiang;Augusto Villanueva;Yujin Hoshida;Yujin Hoshida;Judit Peix

  • Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma

    Elisa Wurmbach;Ying Bei Chen;Greg Khitrov;Weijia Zhang

  • Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients.

    Chao Niu;Hua Yan;Ting Yu;Hui-Ping Sun

  • Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.

    Daniela Sia;Yujin Hoshida;Augusto Villanueva;Sasan Roayaie

  • Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia

    Jiong Hu;Yuan Fang Liu;Chuan Feng Wu;Fang Xu

  • A Molecular Signature to Discriminate Dysplastic Nodules From Early Hepatocellular Carcinoma in HCV Cirrhosis

    Josep M. Llovet;Yingbei Chen;Elisa Wurmbach;Sasan Roayaie

  • History of the Development of Arsenic Derivatives in Cancer Therapy

    Samuel Waxman;Kenneth C. Anderson

  • Arsenic Trioxide as an Inducer of Apoptosis and Loss of PML/RARα Protein in Acute Promyelocytic Leukemia Cells

    W. Shao;M. Fanelli;F. F. Ferrara;R. Riccioni

  • Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17).

    Jonathan D. Licht;Christine Chomienne;Andre Goy;Alex Chen

  • Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression

    Byoung Kwon Yoo;Luni Emdad;Zao-zhong Su;Augusto Villanueva

  • Reduced Retinoic Acid-Sensitivities of Nuclear Receptor Corepressor Binding to PML- and PLZF-RARα Underlie Molecular Pathogenesis and Treatment of Acute Promyelocytic Leukemia

    Fabien Guidez;Sarah Ivins;Sarah Ivins;Sarah Ivins;Jun Zhu;Jun Zhu;Jun Zhu;Mats Söderström;Mats Söderström;Mats Söderström

  • Induction of cell migration by pro-urokinase binding to its receptor : possible mechanism for signal transduction in human epithelial cells

    N Busso;S K Masur;D Lazega;S Waxman

Frequent Co-Authors

Arthur Zelent
Arthur Zelent University of Miami
Jonathan D. Licht
Jonathan D. Licht University of Florida
Josep M. Llovet
Josep M. Llovet University of Barcelona
Zhu Chen
Zhu Chen Shanghai Jiao Tong University
Myron Schwartz
Myron Schwartz Icahn School of Medicine at Mount Sinai
Vincenzo Mazzaferro
Vincenzo Mazzaferro University of Milan
Swan N. Thung
Swan N. Thung Icahn School of Medicine at Mount Sinai
Ming-Ming Zhou
Ming-Ming Zhou Icahn School of Medicine at Mount Sinai
Guo-Qiang Chen
Guo-Qiang Chen Tsinghua University
Scott L. Friedman
Scott L. Friedman Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring alternative or complementary paths to a traditional medical degree in the USA, there are several promising online options. Many students begin or advance their healthcare careers by studying flexible programs that offer direct entry and financial assistance.

For aspiring nurses, online adn programs (Associate Degree in Nursing) provide a way to quickly enter the nursing field. Some do you have to take the teas test to get into nursing school options let you skip standardized entrance exams, removing a significant barrier from the application process.

If you’re interested in behind-the-scenes roles, accredited medical billing and coding schools with financial aid let you earn certifications online with the help of scholarships or grants. This field is vital for keeping healthcare offices running smoothly.

Students who want to lead or manage in healthcare can pursue a health care administration degree online. These programs prepare graduates for roles in hospital management, policy, and administration—offering a fast-track to leadership positions within the industry.

Best Scientists Citing Samuel Waxman

Trending Scientists

Recently Published Articles